The effect of the frequency and duration of prostate specific antigen (PSA) measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer

BACKGROUND: Prostate specific antigen (PSA) doubling time (PSADT) is an attractive intermediate endpoint for assessing novel therapies in biochemically recurrent prostate cancer (BRPC). This study explores whether PSADT calculations are influenced by frequency/duration of PSA measurements, and wheth...

Descripción completa

Detalles Bibliográficos
Autores principales: Paller, CJ, Olatoye, D, Xie, S, Zhou, X, Denmeade, SR, Eisenberger, MA, Antonarakis, ES, Carducci, MA, Rosner, GL
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945997/
https://www.ncbi.nlm.nih.gov/pubmed/24100642
http://dx.doi.org/10.1038/pcan.2013.40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945997/
https://www.ncbi.nlm.nih.gov/pubmed/24100642
http://dx.doi.org/10.1038/pcan.2013.40

Ejemplares similares